Press release
Sarcopenia Market Forecast to Hit USD 4.23 Billion by 2030 with 5.6 Percentage Annual Growth
Sarcopenia Market
๐๐๐ซ๐๐จ๐ฉ๐๐ง๐ข๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ:
The sarcopenia market is witnessing significant growth as awareness about this age-related condition increases worldwide. Sarcopenia, characterized by the progressive loss of muscle mass and strength, primarily affects the aging population, leading to reduced mobility, frailty, and a higher risk of falls and fractures. With the global rise in the elderly demographic, the demand for effective diagnostic tools, therapies, and preventive measures is on the rise. Advances in medical technology and pharmaceuticals, including the development of novel therapies targeting muscle growth and function, are driving the market forward. Additionally, the increasing focus on nutrition, physical activity, and lifestyle interventions for sarcopenia management is contributing to the market's expansion.
๐๐๐ญ ๐๐จ๐ฎ๐ซ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐ญ๐ก๐ ๐๐๐ญ๐๐ฌ๐ญ ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ: https://www.maximizemarketresearch.com/market-report/sarcopenia-market/196035/
๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐๐๐ซ๐๐จ๐ฉ๐๐ง๐ข๐ ๐๐๐ซ๐ค๐๐ญ:
Several key factors are driving the growth of the sarcopenia market, with the aging global population being the most significant. According to the United Nations, the number of people aged 60 and above is expected to double by 2050, highlighting the urgent need for sarcopenia management solutions. Growing awareness among healthcare providers and patients about the condition and its implications has led to an increase in early diagnosis and intervention. The development of targeted therapies, including myostatin inhibitors and anabolic agents, is providing new treatment options. Furthermore, government initiatives promoting healthy aging and investments in research and development are accelerating the availability of innovative solutions for sarcopenia.
๐๐๐ซ๐๐จ๐ฉ๐๐ง๐ข๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐ง๐๐ฌ:
The sarcopenia market is evolving rapidly with emerging trends shaping its growth trajectory. One notable trend is the integration of digital health technologies, such as wearable devices and mobile apps, to monitor muscle health and physical activity levels. These tools enable real-time tracking and personalized interventions, improving patient outcomes. The increasing emphasis on combination therapies, incorporating pharmaceuticals, nutritional supplements, and exercise programs, is another key trend gaining traction. Additionally, the rise of telemedicine has enhanced accessibility to sarcopenia management services, especially in remote and underserved areas. Collaborations between pharmaceutical companies, research institutions, and healthcare providers are fostering innovation, leading to the development of more effective and accessible treatment options. These trends underscore the dynamic nature of the sarcopenia market, positioning it for continued growth.
๐๐ง๐ช๐ฎ๐ข๐ซ๐ ๐๐จ๐๐๐ฒ ๐๐จ๐ซ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ: https://www.maximizemarketresearch.com/market-report/sarcopenia-market/196035/
๐๐๐ซ๐ ๐๐ซ๐ฌ ๐๐ง๐ ๐๐๐ช๐ฎ๐ข๐ฌ๐ข๐ญ๐ข๐จ๐ง๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐๐๐ซ๐๐จ๐ฉ๐๐ง๐ข๐ ๐๐๐ซ๐ค๐๐ญ
๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ ๐ข๐ง ๐๐ข๐๐ญ๐ง๐๐ฆ
Vietnam's sarcopenia market is expanding due to increasing awareness of aging-related health issues and the growing elderly population. The government is actively promoting healthy aging programs, which include nutrition and exercise-based interventions. Collaborations between local healthcare providers and global companies like Nestlรฉ Health Science are driving innovation and accessibility of sarcopenia management solutions in Vietnam.
๐๐ซ๐๐ง๐๐ฌ ๐ข๐ง ๐๐ก๐๐ข๐ฅ๐๐ง๐'๐ฌ ๐๐๐ซ๐๐จ๐ฉ๐๐ง๐ข๐ ๐๐๐ซ๐ค๐๐ญ
Thailand's sarcopenia market benefits from its robust healthcare infrastructure and the country's focus on medical tourism. Companies like Abbott Laboratories are introducing nutritional supplements targeting muscle health, contributing to the growing demand for sarcopenia solutions. The Thai government's initiatives to promote geriatric care are fostering market growth, particularly in urban areas with high aging demographics.
๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ ๐ข๐ง ๐๐๐ฉ๐๐ง'๐ฌ ๐๐๐ซ๐๐จ๐ฉ๐๐ง๐ข๐ ๐๐๐๐ญ๐จ๐ซ
Japan, with one of the world's oldest populations, is a key market for sarcopenia solutions. Companies like Daiichi Sankyo and Astellas Pharma are advancing clinical trials for therapies addressing muscle wasting. Japan's emphasis on healthy aging and its strong focus on R&D are driving the adoption of innovative therapies and diagnostics for sarcopenia.
๐๐๐ซ๐๐จ๐ฉ๐๐ง๐ข๐ ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐ข๐ง ๐๐จ๐ฎ๐ญ๐ก ๐๐จ๐ซ๐๐
South Korea's sarcopenia market is growing due to increasing healthcare spending and advancements in digital health technologies. Companies such as LG Chem are investing in the development of myostatin inhibitors and other therapeutic agents targeting muscle loss. Government initiatives like the Korean National Aging Plan are also promoting awareness and early diagnosis of sarcopenia.
๐๐ซ๐๐ง๐๐ฌ ๐ข๐ง ๐๐ข๐ง๐ ๐๐ฉ๐จ๐ซ๐'๐ฌ ๐๐๐ซ๐ค๐๐ญ
Singapore's sarcopenia market is supported by its advanced healthcare ecosystem and the government's emphasis on healthy aging. Companies such as Eu Yan Sang are leveraging traditional and modern approaches to develop supplements and therapies for muscle health. Singapore's role as a hub for clinical research and innovation in Southeast Asia further accelerates market growth.
๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐๐ ๐๐๐ซ๐๐จ๐ฉ๐๐ง๐ข๐ ๐๐๐ซ๐ค๐๐ญ
The US leads the global sarcopenia market, driven by a large elderly population, robust healthcare infrastructure, and strong R&D investments. Major companies like Pfizer and Amgen are conducting clinical trials for advanced therapies targeting muscle regeneration. Recent mergers, such as Nestlรฉ Health Science's acquisition of nutritional supplement brands, highlight the growing focus on sarcopenia management in the US.
๐๐ซ๐จ๐ฐ๐ญ๐ก ๐ข๐ง ๐๐ฎ๐ซ๐จ๐ฉ๐'๐ฌ ๐๐๐ซ๐๐จ๐ฉ๐๐ง๐ข๐ ๐๐๐ซ๐ค๐๐ญ
Europe is a significant market for sarcopenia, with countries like Germany, France, and the UK focusing on geriatric care. Companies like GlaxoSmithKline and Novartis are investing in the development of combination therapies and diagnostics. The European Union's Healthy Aging programs and cross-border collaborations are further fueling market growth.
๐๐ฎ๐ซ๐ข๐จ๐ฎ๐ฌ ๐๐๐จ๐ฎ๐ญ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐ง๐๐ฌ? ๐๐ซ๐๐ ๐๐จ๐ฎ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ๐๐๐ฒ: https://www.maximizemarketresearch.com/market-report/sarcopenia-market/196035/
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ซ๐๐จ๐ฉ๐๐ง๐ข๐ ๐๐๐ซ๐ค๐๐ญ:
by Treatment Type
Protein Supplement
Vitamin B12 Supplement
Vitamin D & Calcium Supplement
Exercise therapy
Pharmacotherapy
Others
by Route of Administration
Oral
Parenteral
Enteral
by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
by End-User
Hospitals
Clinics
Homecare settings
๐๐ก๐จ ๐ข๐ฌ ๐ญ๐ก๐ ๐ฅ๐๐ซ๐ ๐๐ฌ๐ญ ๐ฆ๐๐ง๐ฎ๐๐๐๐ญ๐ฎ๐ซ๐๐ซ๐ฌ ๐จ๐ ๐๐๐ซ๐๐จ๐ฉ๐๐ง๐ข๐ ๐๐๐ซ๐ค๐๐ญ ๐ฐ๐จ๐ซ๐ฅ๐๐ฐ๐ข๐๐?
1. Bayer AG
2. Zydus Cadila
3. GlaxoSmithKline plc
4. Nestle Health Science
5. Sanofi S.A.
6. GlaxoSmithKline plc.
7. Novartis AG
8. Pfizer Inc.
9. AstaReal AB
10. Merck Sharp & Dohme Corp.
11. AbbVie Inc.
12. Abbott laboratories, Inc.
13. American Way (Amway) Corporation
14. F-Hoffmann La-Roche
15. Amgen Inc.
16. Johnson & Johnson
๐๐ง๐จ๐ฐ ๐๐จ๐ซ๐ ๐๐๐จ๐ฎ๐ญ ๐๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.maximizemarketresearch.com/market-report/sarcopenia-market/196035/
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐จ๐ซ๐: ๐๐ข๐ฌ๐ข๐ญ ๐๐ฎ๐ซ ๐๐๐๐ฌ๐ข๐ญ๐ ๐๐จ๐ซ ๐๐๐๐ข๐ญ๐ข๐จ๐ง๐๐ฅ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
โฆglobal Invisible Orthodontics Market https://www.maximizemarketresearch.com/market-report/global-invisible-orthodontics-market/102627/
โฆDRAM Market https://www.maximizemarketresearch.com/market-report/global-dram-market/53352/
โฆThermal Management Market https://www.maximizemarketresearch.com/market-report/thermal-management-market/11222/
โฆSolar Backsheet Market https://www.maximizemarketresearch.com/market-report/global-solar-backsheet-market/25895/
โฆWater Transport Market https://www.maximizemarketresearch.com/market-report/water-transport-market/164097/
โฆMicrogrid Market https://www.maximizemarketresearch.com/market-report/global-microgrid-market/22049/
โฆPersonal Care Ingredients Market https://www.maximizemarketresearch.com/market-report/global-personal-care-ingredients-market/57911/
MAXIMIZE MARKET RESEARCH PVT. LTD.
โฎ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
โ +91 9607365656
๐ sales@maximizemarketresearch.com
๐ www.maximizemarketresearch.com
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sarcopenia Market Forecast to Hit USD 4.23 Billion by 2030 with 5.6 Percentage Annual Growth here
News-ID: 3821557 • Views: โฆ
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.
Bangladesh Ceramics Tiles Market to Surpass USD 2.1 Billion by 2030, Fueled by a โฆ
Bangladesh Ceramics Tiles Market size was valued at USD 882.56 Million in 2023 and the total Bangladesh Ceramics Tiles Market revenue is expected to grow at a CAGR of 13.71 % from 2024 to 2030, reaching nearly USD 2169.38 Million.
Bangladesh Ceramics Tiles Market Overview:
The Bangladesh ceramics tiles market is a vital component of the country's construction and building materials industry, driven by rapid urbanization, infrastructure development, and rising disposable incomes.โฆ
Furfural Market to Reach Nearly USD 1 Trillion by 2030, Propelled by a 6.8% CAGR
Furfural Market size was valued at USD 630.2Mn in 2023. The Furfural Market revenue is growing at a CAGR of 6.8 % from 2023 to 2029, reaching nearly USD 998.30 Bn by 2030.
Furfural Market Overview:
The furfural market is centered around an organic compound derived primarily from agricultural byproducts such as corn cobs, sugarcane bagasse, and rice husks through a process of acid hydrolysis. As one of the oldest renewable chemicals,โฆ
Chemical Protective Clothing Market Valued at USD 1.57 Bn in 2024, Projected to โฆ
Chemical Protective Clothing Market size was valued at USD 1.57 Billion in 2024 and the total Chemical Protective Clothing revenue is expected to grow at a CAGR of 5.59% from 2025 to 2032, reaching nearly USD 2.42 Billion.
Chemical Protective Clothing Market Overview:
The Chemical Protective Clothing (CPC) market comprises garments and accessories specifically designed to shield workers from exposure to hazardous chemicals, liquids, and particulate matter across a wide range ofโฆ
Prefabricated Homes Market Valued at USD 18.58 Bn in 2024, Poised for 6.19% CAGR โฆ
Prefabricated Homes Market size was valued at USD 18.58 Billion in 2024 and the total Prefabricated Homes revenue is expected to grow at a CAGR of 6.19% from 2025 to 2032, reaching nearly USD 30.04 Billion.
Prefabricated Homes Market Overview:
The prefabricated homes market, also known as modular or off-site construction, involves the manufacturing of building components in a controlled factory environment before their assembly at the final location. This method revolutionizesโฆ
More Releases for Sarcopenia
Sarcopenia Market Size, Share & Growth Analysis 2034
Sarcopenia Market Overview
Sarcopenia is a condition characterized by the progressive loss of muscle mass, strength, and function, primarily affecting the elderly. This decline leads to increased frailty, higher risk of falls, and diminished quality of life. The rising global geriatric population has heightened the prevalence of sarcopenia, making it a significant public health concern. Consequently, there is a growing demand for effective treatments and interventions to manage and mitigate theโฆ
Sarcopenia Treatment Market Future Prediction Report By 2030
Sarcopenia Treatment Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics.โฆ
Sarcopenia Treatment Market Report 2024 - Sarcopenia Treatment Market Size And G โฆ
"The Business Research Company recently released a comprehensive report on the Global Sarcopenia Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The sarcopenia treatment marketโฆ
Sarcopenia Pipeline Insights Report 2023 (Updated)
(Albany, United States) As per DelveInsight's assessment, globally, the Sarcopenia Pipeline constitutes 8+ key companies continuously working towards developing 10+ Sarcopenia Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
In the Sarcopenia Pipeline Report, a detailed description of the drug is given which includes the mechanism of action of the drug, clinical studies, Sarcopenia NDA approvals (if any), and productโฆ
Global Sarcopenia Therapeutic Market Research Report 2023
The global Sarcopenia Therapeutic market was valued at US$ 2867.6 million in 2022 and is anticipated to reach US$ 3484.4 million by 2029, witnessing a CAGR of 3.3% during the forecast period 2023-2029.
view full report
https://reports.valuates.com/market-reports/QYRE-Auto-13K14453/global-sarcopenia-therapeutic
Sarcopenia Therapeutic Market
Sarcopenia is a syndrome caused by continuous loss of skeletal muscle mass, strength, and function.
The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
China is the largest consumption region ofโฆ
Sarcopenia - Drug Pipeline Landscape, 2022
Sarcopenia is a condition characterized by the loss of muscle mass and strength. It can occur due to a variety of reasons, including aging, inactivity, and certain chronic diseases.
Aging is the most common cause of sarcopenia. As people age, they tend to become less active and lose muscle mass. This process is known as age-related muscle loss or sarcopenia with aging.
Inactivity can also lead to sarcopenia. People who are notโฆ
